Clinical Trials List
Protocol Number2020-03-005A
Active
2022-02-01 - 2026-12-31
Others
Recruiting1
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- 林可瀚 Division of Nuclear Medicine
- Yi-Fang Tsai Division of General Surgery
- Ling-Ming Tseng Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
195 participants
-
Global
195 participants
